advertisement
Riva I 13
Showing records 1 to 13 | Display all abstracts from Riva I91978 Glaucoma and neuroinflammation: An overview
Quaranta L
Survey of Ophthalmology 2021; 66: 693-713
92335 Human recombinant nerve growth factor (Cenegermin) in a patient affected by primary congenital glaucoma with neurotrophic keratopathy
Riva I; Micheletti E
European Journal of Ophthalmology 2021; 0: 1120672121999344
91978 Glaucoma and neuroinflammation: An overview
Bruttini C
Survey of Ophthalmology 2021; 66: 693-713
92335 Human recombinant nerve growth factor (Cenegermin) in a patient affected by primary congenital glaucoma with neurotrophic keratopathy
Micheletti E
European Journal of Ophthalmology 2021; 0: 1120672121999344
91978 Glaucoma and neuroinflammation: An overview
Micheletti E; Micheletti E
Survey of Ophthalmology 2021; 66: 693-713
92335 Human recombinant nerve growth factor (Cenegermin) in a patient affected by primary congenital glaucoma with neurotrophic keratopathy
Fausto R; Bruttini C
European Journal of Ophthalmology 2021; 0: 1120672121999344
91978 Glaucoma and neuroinflammation: An overview
Konstas AGP
Survey of Ophthalmology 2021; 66: 693-713
92335 Human recombinant nerve growth factor (Cenegermin) in a patient affected by primary congenital glaucoma with neurotrophic keratopathy
De Angelis G
European Journal of Ophthalmology 2021; 0: 1120672121999344
91978 Glaucoma and neuroinflammation: An overview
Michelessi M; Oddone F
Survey of Ophthalmology 2021; 66: 693-713
92335 Human recombinant nerve growth factor (Cenegermin) in a patient affected by primary congenital glaucoma with neurotrophic keratopathy
Ceccuzzi R
European Journal of Ophthalmology 2021; 0: 1120672121999344
91978 Glaucoma and neuroinflammation: An overview
Katsanos A
Survey of Ophthalmology 2021; 66: 693-713
92335 Human recombinant nerve growth factor (Cenegermin) in a patient affected by primary congenital glaucoma with neurotrophic keratopathy
Quaranta L
European Journal of Ophthalmology 2021; 0: 1120672121999344
91978 Glaucoma and neuroinflammation: An overview
Sbardella D; Sbardella D; De Angelis G; Riva I
Survey of Ophthalmology 2021; 66: 693-713
